Perhaps timely catching Caribou Biosciences Inc (CRBU) would be a good idea

With 1.13 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.43 million shares. The 52-week range on CRBU shows that it touched its highest point at $8.33 and its lowest point at $1.22 during that stretch. It currently has a 1-year price target of $13.25. Beta for the stock currently stands at 2.32.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CRBU was down-trending over the past week, with a drop of -12.68%, but this was down by -17.88% over a month. Three-month performance dropped to -36.73% while six-month performance fell -40.67%. The stock lost -82.08% in the past year, while it has lost -22.01% so far this year. A look at the trailing 12-month EPS for CRBU yields -1.65 with Next year EPS estimates of -1.86. For the next quarter, that number is -0.42. This implies an EPS growth rate of -20.17% for this year and -12.11% for next year. EPS is expected to decline by -12.22% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -37.16%.

Float and Shares Shorts:

At present, 90.55 million CRBU shares are outstanding with a float of 79.17 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CRBU since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.4966 being high and -$1.73929 being low. For CRBU, this leads to a yearly average estimate of -$1.65839. Based on analyst estimates, the high estimate for the next quarter is -$0.44 and the low estimate is -$0.44. The average estimate for the next quarter is thus -$0.44.